These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9893762)

  • 1. The provision of renal replacement therapy for adults in England and Wales: recent trends and future directions.
    Roderick PJ; Ferris G; Feest TG
    QJM; 1998 Aug; 91(8):581-7. PubMed ID: 9893762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation model of renal replacement therapy: predicting future demand in England.
    Roderick P; Davies R; Jones C; Feest T; Smith S; Farrington K
    Nephrol Dial Transplant; 2004 Mar; 19(3):692-701. PubMed ID: 14767028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of gender, age, and geographical location on the incidence and prevalence of renal replacement therapy in Wales.
    van Woerden HC; Wilkinson J; Heaven M; Merrifield J
    BMC Nephrol; 2007 Jan; 8():1. PubMed ID: 17217542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need and demand for renal replacement therapy in ethnic minorities in England.
    Roderick PJ; Raleigh VS; Hallam L; Mallick NP
    J Epidemiol Community Health; 1996 Jun; 50(3):334-9. PubMed ID: 8935467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in adult renal replacement therapy in the UK: 1982-2002.
    Feest TG; Rajamahesh J; Byrne C; Ahmad A; Ansell D; Burden R; Roderick PJ
    QJM; 2005 Jan; 98(1):21-8. PubMed ID: 15625350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales.
    Roderick P; Nicholson T; Armitage A; Mehta R; Mullee M; Gerard K; Drey N; Feest T; Greenwood R; Lamping D; Townsend J
    Health Technol Assess; 2005 Jul; 9(24):1-178. PubMed ID: 15985188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equity of access to dialysis facilities in Wales.
    White P; James V; Ansell D; Lodhi V; Donovan KL
    QJM; 2006 Jul; 99(7):445-52. PubMed ID: 16682437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 1 UK RRT incidence in 2010: national and centre-specific analyses.
    Gilg J; Castledine C; Fogarty D
    Nephron Clin Pract; 2012; 120 Suppl 1():c1-27. PubMed ID: 22964563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment.
    Feest TG; Mistry CD; Grimes DS; Mallick NP
    BMJ; 1990 Oct; 301(6757):897-900. PubMed ID: 2261533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy.
    Fotheringham J; Fogarty D; Jacques R; El Nahas M; Campbell M
    Nephron Clin Pract; 2012; 120 Suppl 1():c247-60. PubMed ID: 22964571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 10 Blood pressure profile of prevalent patients receiving renal replacement therapy in England, Wales and Northern Ireland in 2010: national and centre-specific analyses.
    Caskey F; Webb L; Pitcher D; Farrington K
    Nephron Clin Pract; 2012; 120 Suppl 1():c211-8. PubMed ID: 22964568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of renal service provision in south and mid Wales.
    Christie S; Morgan G; Heaven M; Sandifer Q; Woerden Hv
    Public Health; 2005 Aug; 119(8):738-42. PubMed ID: 15949526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New adult patients starting renal replacement therapy in the UK in 2005 (chapter 3).
    Farrington K; Rao R; Gilg J; Ansell D; Feest T
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii11-29. PubMed ID: 17724040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Study of Health Care Organization and Financing of renal services in England and Wales.
    Nicholson T; Roderick P
    Int J Health Care Finance Econ; 2007 Dec; 7(4):283-99. PubMed ID: 17653861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All patients receiving renal replacement therapy in the United Kingdom in 2005 (chapter 4).
    Farrington K; Rao R; Stenkamp R; Ansell D; Feest T
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii30-50. PubMed ID: 17724051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population need for renal replacement therapy in Thames regions: ethnic dimension.
    Roderick PJ; Jones I; Raleigh VS; McGeown M; Mallick N
    BMJ; 1994 Oct; 309(6962):1111-4. PubMed ID: 7987102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
    Shaw C; Simms RJ; Pitcher D; Sandford R
    Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.
    Webb L; Gilg J; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c85-96. PubMed ID: 21894042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK Renal Registry 16th annual report: chapter 2 UK RRT prevalence in 2012: national and centre-specific analyses.
    Shaw C; Pitcher D; Pruthi R; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):29-53. PubMed ID: 24662166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.